BFC Planning’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-12
Closed -$900 – 3532
2026
Q2
$900 Buy
+12
New +$771 ﹤0.01% 3169

Other funds holding HAE

BFC Planning's HAE Position: Q3 2026 in Review

BFC Planning sold out of Haemonetics (HAE) in Q3 2026, closing a stake of 12 shares — an estimated $900 sold.

BFC Planning first reported a position in HAE in Q2 2026 and held it in 1 quarter. The position peaked at $900 in Q2 2026. 269 funds tracked by Wall St. Rank hold HAE as of Q3 2026.

  • BFC Planning reported no remaining Haemonetics position as of Q3 2026 after selling out during the quarter.
  • BFC Planning sold 12 Haemonetics shares in Q3 2026, an estimated $900.
  • BFC Planning first reported a position in Haemonetics in Q2 2026 and held it in 1 quarter.
  • BFC Planning's Haemonetics position peaked at $900 in Q2 2026.
  • 269 funds tracked by Wall St. Rank held Haemonetics as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.